img

Global and United States Central Nervous System Disease Drugs Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Central Nervous System Disease Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Central Nervous System Disease Drugs Market
This report focuses on global and United States Central Nervous System Disease Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Central Nervous System Disease Drugs revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Central Nervous System Disease Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Central Nervous System Disease Drugs include Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck and GSK, etc. The global five biggest players hold a share of % in 2024.
Global Central Nervous System Disease Drugs Scope and Market Size
Central Nervous System Disease Drugs market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Central Nervous System Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Central Nervous System Disease Drugs market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Pfizer
Biogen
Otsuka
Novartis
Teva Pharmaceutical
Johnson & Johnson
AstraZeneca
Merck
GSK
Eli Lilly and Company
Lundbeck
Takeda
Bristol Myers Squibb
Jiangsu Nhwa Pharmaceutical
Luye Pharma
Zhejiang Huahai Pharmaceutical
Chengdu Easton Biopharmaceuticals
Hansoh Pharmaceutical
Segment by Type
Antidepressants
Antipsychotics
Anti-Dementia Drugs
Anti-Parkinson's Drugs
Antiepileptic Drugs
Others

Segment by Application


Hospital and Clinic
Pharmacy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Central Nervous System Disease Drugs definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Central Nervous System Disease Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Central Nervous System Disease Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Central Nervous System Disease Drugs revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Central Nervous System Disease Drugs Product Introduction
1.2 Global Central Nervous System Disease Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Central Nervous System Disease Drugs Market Size for the Year 2018-2034
1.2.2 United States Central Nervous System Disease Drugs Market Size for the Year 2018-2034
1.3 Central Nervous System Disease Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Central Nervous System Disease Drugs in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Central Nervous System Disease Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Central Nervous System Disease Drugs Market Dynamics
1.4.1 Central Nervous System Disease Drugs Industry Trends
1.4.2 Central Nervous System Disease Drugs Market Drivers
1.4.3 Central Nervous System Disease Drugs Market Challenges
1.4.4 Central Nervous System Disease Drugs Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Central Nervous System Disease Drugs by Type
2.1 Central Nervous System Disease Drugs Market Segment by Type
2.1.1 Antidepressants
2.1.2 Antipsychotics
2.1.3 Anti-Dementia Drugs
2.1.4 Anti-Parkinson's Drugs
2.1.5 Antiepileptic Drugs
2.1.6 Others
2.2 Global Central Nervous System Disease Drugs Market Size by Type (2018, 2024 & 2034)
2.3 Global Central Nervous System Disease Drugs Market Size by Type (2018-2034)
2.4 United States Central Nervous System Disease Drugs Market Size by Type (2018, 2024 & 2034)
2.5 United States Central Nervous System Disease Drugs Market Size by Type (2018-2034)
3 Central Nervous System Disease Drugs by Application
3.1 Central Nervous System Disease Drugs Market Segment by Application
3.1.1 Hospital and Clinic
3.1.2 Pharmacy
3.2 Global Central Nervous System Disease Drugs Market Size by Application (2018, 2024 & 2034)
3.3 Global Central Nervous System Disease Drugs Market Size by Application (2018-2034)
3.4 United States Central Nervous System Disease Drugs Market Size by Application (2018, 2024 & 2034)
3.5 United States Central Nervous System Disease Drugs Market Size by Application (2018-2034)
4 Global Central Nervous System Disease Drugs Competitor Landscape by Company
4.1 Global Central Nervous System Disease Drugs Market Size by Company
4.1.1 Global Key Companies of Central Nervous System Disease Drugs, Ranked by Revenue (2024)
4.1.2 Global Central Nervous System Disease Drugs Revenue by Player (2018-2023)
4.2 Global Central Nervous System Disease Drugs Concentration Ratio (CR)
4.2.1 Central Nervous System Disease Drugs Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Central Nervous System Disease Drugs in 2024
4.2.3 Global Central Nervous System Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Central Nervous System Disease Drugs Head office and Area Served
4.4 Global Key Players of Central Nervous System Disease Drugs, Product and Application
4.5 Global Key Players of Central Nervous System Disease Drugs, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Central Nervous System Disease Drugs Market Size by Company
4.7.1 Key Players of Central Nervous System Disease Drugs in United States, Ranked by Revenue (2024)
4.7.2 United States Central Nervous System Disease Drugs Revenue by Players (2021, 2024 & 2023)
5 Global Central Nervous System Disease Drugs Market Size by Region
5.1 Global Central Nervous System Disease Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Central Nervous System Disease Drugs Market Size by Region (2018-2034)
5.2.1 Global Central Nervous System Disease Drugs Market Size by Region: 2018-2023
5.2.2 Global Central Nervous System Disease Drugs Market Size by Region (2024-2034)
6 Americas
6.1 Americas Central Nervous System Disease Drugs Market Size YoY Growth 2018-2034
6.2 Americas Central Nervous System Disease Drugs Market Size by Type
6.2.1 Americas Central Nervous System Disease Drugs Market Size by Type (2018-2023)
6.2.2 Americas Central Nervous System Disease Drugs Market Size by Type (2024-2034)
6.2.3 Americas Central Nervous System Disease Drugs Market Share by Type (2018-2034)
6.3 Americas Central Nervous System Disease Drugs Market Size by Application
6.3.1 Americas Central Nervous System Disease Drugs Market Size by Application (2018-2023)
6.3.2 Americas Central Nervous System Disease Drugs Market Size by Application (2024-2034)
6.3.3 Americas Central Nervous System Disease Drugs Market Share by Application (2018-2034)
6.4 Americas Central Nervous System Disease Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Central Nervous System Disease Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Central Nervous System Disease Drugs Market Size by Type
7.2.1 EMEA Central Nervous System Disease Drugs Market Size by Type (2018-2023)
7.2.2 EMEA Central Nervous System Disease Drugs Market Size by Type (2024-2034)
7.2.3 EMEA Central Nervous System Disease Drugs Market Share by Type (2018-2034)
7.3 EMEA Central Nervous System Disease Drugs Market Size by Application
7.3.1 EMEA Central Nervous System Disease Drugs Market Size by Application (2018-2023)
7.3.2 EMEA Central Nervous System Disease Drugs Market Size by Application (2024-2034)
7.3.3 EMEA Central Nervous System Disease Drugs Market Share by Application (2018-2034)
7.4 EMEA Central Nervous System Disease Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Central Nervous System Disease Drugs Market Size YoY Growth 2018-2034
8.2 China Central Nervous System Disease Drugs Market Size by Type
8.2.1 China Central Nervous System Disease Drugs Market Size by Type (2018-2023)
8.2.2 China Central Nervous System Disease Drugs Market Size by Type (2024-2034)
8.2.3 China Central Nervous System Disease Drugs Market Share by Type (2018-2034)
8.3 China Central Nervous System Disease Drugs Market Size by Application
8.3.1 China Central Nervous System Disease Drugs Market Size by Application (2018-2023)
8.3.2 China Central Nervous System Disease Drugs Market Size by Application (2024-2034)
8.3.3 China Central Nervous System Disease Drugs Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Central Nervous System Disease Drugs Market Size YoY Growth 2018-2034
9.2 APAC Central Nervous System Disease Drugs Market Size by Type
9.2.1 APAC Central Nervous System Disease Drugs Market Size by Type (2018-2023)
9.2.2 APAC Central Nervous System Disease Drugs Market Size by Type (2024-2034)
9.2.3 APAC Central Nervous System Disease Drugs Market Share by Type (2018-2034)
9.3 APAC Central Nervous System Disease Drugs Market Size by Application
9.3.1 APAC Central Nervous System Disease Drugs Market Size by Application (2018-2023)
9.3.2 APAC Central Nervous System Disease Drugs Market Size by Application (2024-2034)
9.3.3 APAC Central Nervous System Disease Drugs Market Share by Application (2018-2034)
9.4 APAC Central Nervous System Disease Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Pfizer Business Overview
10.1.3 Pfizer Central Nervous System Disease Drugs Introduction
10.1.4 Pfizer Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.1.5 Pfizer Recent Development
10.2 Biogen
10.2.1 Biogen Company Details
10.2.2 Biogen Business Overview
10.2.3 Biogen Central Nervous System Disease Drugs Introduction
10.2.4 Biogen Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.2.5 Biogen Recent Development
10.3 Otsuka
10.3.1 Otsuka Company Details
10.3.2 Otsuka Business Overview
10.3.3 Otsuka Central Nervous System Disease Drugs Introduction
10.3.4 Otsuka Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.3.5 Otsuka Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Novartis Business Overview
10.4.3 Novartis Central Nervous System Disease Drugs Introduction
10.4.4 Novartis Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.4.5 Novartis Recent Development
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Company Details
10.5.2 Teva Pharmaceutical Business Overview
10.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Introduction
10.5.4 Teva Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.5.5 Teva Pharmaceutical Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Details
10.6.2 Johnson & Johnson Business Overview
10.6.3 Johnson & Johnson Central Nervous System Disease Drugs Introduction
10.6.4 Johnson & Johnson Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.6.5 Johnson & Johnson Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Details
10.7.2 AstraZeneca Business Overview
10.7.3 AstraZeneca Central Nervous System Disease Drugs Introduction
10.7.4 AstraZeneca Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.7.5 AstraZeneca Recent Development
10.8 Merck
10.8.1 Merck Company Details
10.8.2 Merck Business Overview
10.8.3 Merck Central Nervous System Disease Drugs Introduction
10.8.4 Merck Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.8.5 Merck Recent Development
10.9 GSK
10.9.1 GSK Company Details
10.9.2 GSK Business Overview
10.9.3 GSK Central Nervous System Disease Drugs Introduction
10.9.4 GSK Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.9.5 GSK Recent Development
10.10 Eli Lilly and Company
10.10.1 Eli Lilly and Company Company Details
10.10.2 Eli Lilly and Company Business Overview
10.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Introduction
10.10.4 Eli Lilly and Company Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.10.5 Eli Lilly and Company Recent Development
10.11 Lundbeck
10.11.1 Lundbeck Company Details
10.11.2 Lundbeck Business Overview
10.11.3 Lundbeck Central Nervous System Disease Drugs Introduction
10.11.4 Lundbeck Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.11.5 Lundbeck Recent Development
10.12 Takeda
10.12.1 Takeda Company Details
10.12.2 Takeda Business Overview
10.12.3 Takeda Central Nervous System Disease Drugs Introduction
10.12.4 Takeda Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.12.5 Takeda Recent Development
10.13 Bristol Myers Squibb
10.13.1 Bristol Myers Squibb Company Details
10.13.2 Bristol Myers Squibb Business Overview
10.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Introduction
10.13.4 Bristol Myers Squibb Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.13.5 Bristol Myers Squibb Recent Development
10.14 Jiangsu Nhwa Pharmaceutical
10.14.1 Jiangsu Nhwa Pharmaceutical Company Details
10.14.2 Jiangsu Nhwa Pharmaceutical Business Overview
10.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Introduction
10.14.4 Jiangsu Nhwa Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.14.5 Jiangsu Nhwa Pharmaceutical Recent Development
10.15 Luye Pharma
10.15.1 Luye Pharma Company Details
10.15.2 Luye Pharma Business Overview
10.15.3 Luye Pharma Central Nervous System Disease Drugs Introduction
10.15.4 Luye Pharma Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.15.5 Luye Pharma Recent Development
10.16 Zhejiang Huahai Pharmaceutical
10.16.1 Zhejiang Huahai Pharmaceutical Company Details
10.16.2 Zhejiang Huahai Pharmaceutical Business Overview
10.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Introduction
10.16.4 Zhejiang Huahai Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.16.5 Zhejiang Huahai Pharmaceutical Recent Development
10.17 Chengdu Easton Biopharmaceuticals
10.17.1 Chengdu Easton Biopharmaceuticals Company Details
10.17.2 Chengdu Easton Biopharmaceuticals Business Overview
10.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Introduction
10.17.4 Chengdu Easton Biopharmaceuticals Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.17.5 Chengdu Easton Biopharmaceuticals Recent Development
10.18 Hansoh Pharmaceutical
10.18.1 Hansoh Pharmaceutical Company Details
10.18.2 Hansoh Pharmaceutical Business Overview
10.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Introduction
10.18.4 Hansoh Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023)
10.18.5 Hansoh Pharmaceutical Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Central Nervous System Disease Drugs Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Central Nervous System Disease Drugs Market Trends
Table 3. Central Nervous System Disease Drugs Market Drivers
Table 4. Central Nervous System Disease Drugs Market Challenges
Table 5. Central Nervous System Disease Drugs Market Restraints
Table 6. Global Central Nervous System Disease Drugs Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Central Nervous System Disease Drugs Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Central Nervous System Disease Drugs Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Central Nervous System Disease Drugs Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Central Nervous System Disease Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Central Nervous System Disease Drugs Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Central Nervous System Disease Drugs Revenue Share by Player, 2018-2023
Table 13. Global Central Nervous System Disease Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disease Drugs as of 2024)
Table 15. Global Key Players of Central Nervous System Disease Drugs, Headquarters and Area Served
Table 16. Global Key Players of Central Nervous System Disease Drugs, Product and Application
Table 17. Global Key Players of Central Nervous System Disease Drugs, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Central Nervous System Disease Drugs in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Central Nervous System Disease Drugs Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Central Nervous System Disease Drugs Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Central Nervous System Disease Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Central Nervous System Disease Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Central Nervous System Disease Drugs Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Central Nervous System Disease Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Central Nervous System Disease Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Central Nervous System Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Central Nervous System Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Central Nervous System Disease Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Central Nervous System Disease Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Central Nervous System Disease Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Central Nervous System Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Central Nervous System Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Central Nervous System Disease Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Central Nervous System Disease Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Central Nervous System Disease Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Central Nervous System Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Central Nervous System Disease Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Central Nervous System Disease Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Central Nervous System Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Central Nervous System Disease Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Central Nervous System Disease Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 51. Pfizer Company Details
Table 52. Pfizer Business Overview
Table 53. Pfizer Central Nervous System Disease Drugs Product
Table 54. Pfizer Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Biogen Company Details
Table 57. Biogen Business Overview
Table 58. Biogen Central Nervous System Disease Drugs Product
Table 59. Biogen Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 60. Biogen Recent Development
Table 61. Otsuka Company Details
Table 62. Otsuka Business Overview
Table 63. Otsuka Central Nervous System Disease Drugs Product
Table 64. Otsuka Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 65. Otsuka Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Central Nervous System Disease Drugs Product
Table 69. Novartis Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Teva Pharmaceutical Company Details
Table 72. Teva Pharmaceutical Business Overview
Table 73. Teva Pharmaceutical Central Nervous System Disease Drugs Product
Table 74. Teva Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 75. Teva Pharmaceutical Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Central Nervous System Disease Drugs Product
Table 79. Johnson & Johnson Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Central Nervous System Disease Drugs Product
Table 84. AstraZeneca Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Central Nervous System Disease Drugs Product
Table 89. Merck Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 90. Merck Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Central Nervous System Disease Drugs Product
Table 94. GSK Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 95. GSK Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Central Nervous System Disease Drugs Product
Table 99. Eli Lilly and Company Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 100. Eli Lilly and Company Recent Development
Table 101. Lundbeck Company Details
Table 102. Lundbeck Business Overview
Table 103. Lundbeck Central Nervous System Disease Drugs Product
Table 104. Lundbeck Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 105. Lundbeck Recent Development
Table 106. Takeda Company Details
Table 107. Takeda Business Overview
Table 108. Takeda Central Nervous System Disease Drugs Product
Table 109. Takeda Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 110. Takeda Recent Development
Table 111. Bristol Myers Squibb Company Details
Table 112. Bristol Myers Squibb Business Overview
Table 113. Bristol Myers Squibb Central Nervous System Disease Drugs Product
Table 114. Bristol Myers Squibb Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 115. Bristol Myers Squibb Recent Development
Table 116. Jiangsu Nhwa Pharmaceutical Company Details
Table 117. Jiangsu Nhwa Pharmaceutical Business Overview
Table 118. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product
Table 119. Jiangsu Nhwa Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 120. Jiangsu Nhwa Pharmaceutical Recent Development
Table 121. Luye Pharma Company Details
Table 122. Luye Pharma Business Overview
Table 123. Luye Pharma Central Nervous System Disease Drugs Product
Table 124. Luye Pharma Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 125. Luye Pharma Recent Development
Table 126. Zhejiang Huahai Pharmaceutical Company Details
Table 127. Zhejiang Huahai Pharmaceutical Business Overview
Table 128. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product
Table 129. Zhejiang Huahai Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 130. Zhejiang Huahai Pharmaceutical Recent Development
Table 131. Chengdu Easton Biopharmaceuticals Company Details
Table 132. Chengdu Easton Biopharmaceuticals Business Overview
Table 133. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product
Table 134. Chengdu Easton Biopharmaceuticals Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 135. Chengdu Easton Biopharmaceuticals Recent Development
Table 136. Hansoh Pharmaceutical Company Details
Table 137. Hansoh Pharmaceutical Business Overview
Table 138. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product
Table 139. Hansoh Pharmaceutical Revenue in Central Nervous System Disease Drugs Business (2018-2023) & (US$ Million)
Table 140. Hansoh Pharmaceutical Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Central Nervous System Disease Drugs Product Picture
Figure 2. Global Central Nervous System Disease Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Central Nervous System Disease Drugs Market Size 2018-2034 (US$ Million)
Figure 4. United States Central Nervous System Disease Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Central Nervous System Disease Drugs Market Size 2018-2034 (US$ Million)
Figure 6. United States Central Nervous System Disease Drugs Market Share in Global 2018-2034
Figure 7. Central Nervous System Disease Drugs Report Years Considered
Figure 8. Product Picture of Antidepressants
Figure 9. Product Picture of Antipsychotics
Figure 10. Product Picture of Anti-Dementia Drugs
Figure 11. Product Picture of Anti-Parkinson's Drugs
Figure 12. Product Picture of Antiepileptic Drugs
Figure 13. Product Picture of Others
Figure 14. Global Central Nervous System Disease Drugs Market Share by Type in 2024 & 2034
Figure 15. Global Central Nervous System Disease Drugs Market Size by Type (2018-2034) & (US$ Million)
Figure 16. Global Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 17. United States Central Nervous System Disease Drugs Market Share by Type in 2024 & 2034
Figure 18. United States Central Nervous System Disease Drugs Market Size by Type (2018-2034) & (US$ Million)
Figure 19. United States Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 20. Product Picture of Hospital and Clinic
Figure 21. Product Picture of Pharmacy
Figure 22. Global Central Nervous System Disease Drugs Market Share by Application in 2024 & 2034
Figure 23. Global Central Nervous System Disease Drugs Market Size by Application (2018-2034) & (US$ Million)
Figure 24. Global Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 25. United States Central Nervous System Disease Drugs Market Share by Application in 2024 & 2034
Figure 26. United States Central Nervous System Disease Drugs Market Size by Application (2018-2034) & (US$ Million)
Figure 27. United States Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 28. The Top 5 and 10 Largest Companies of Central Nervous System Disease Drugs in the World: Market Share by Central Nervous System Disease Drugs Revenue in 2024
Figure 29. Global Central Nervous System Disease Drugs Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 30. Global Central Nervous System Disease Drugs Market Share by Region (2018-2034)
Figure 31. Americas Central Nervous System Disease Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 32. Americas Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 33. Americas Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 34. United States Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Canada Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Mexico Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. Brazil Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. EMEA Central Nervous System Disease Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 39. EMEA Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 40. EMEA Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 41. Europe Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Middle East Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. Africa Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Central Nervous System Disease Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. China Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 46. China Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 47. APAC Central Nervous System Disease Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 48. APAC Central Nervous System Disease Drugs Market Share by Type (2018-2034)
Figure 49. APAC Central Nervous System Disease Drugs Market Share by Application (2018-2034)
Figure 50. Japan Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. South Korea Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. China Taiwan Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. India Central Nervous System Disease Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 56. Biogen Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 57. Otsuka Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 60. Johnson & Johnson Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 61. AstraZeneca Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 63. GSK Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 65. Lundbeck Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 66. Takeda Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 67. Bristol Myers Squibb Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 68. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 69. Luye Pharma Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 70. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 71. Chengdu Easton Biopharmaceuticals Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 72. Hansoh Pharmaceutical Revenue Growth Rate in Central Nervous System Disease Drugs Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries